全球泌尿支架市場 - 市場規模（依細分市場）、佔有率、監管、償付、程序、預測（~2033）

尿路結石症是一種尿液中的化學物質沉澱並形成固體物體（稱為腎結石）的疾病。腎結石形成後，可能留在腎臟或沿著尿路進入輸尿管。腎結石由多種物質形成，包括草酸鹽、尿酸、鳥糞石和胱氨酸。尿路結石和良性前列腺增生（BPH）治療方法的不斷增加，特別是那些需要支架置入或反覆支架置入的治療，是泌尿支架市場的主要成長動力。

本報告研究和分析了全球泌尿支架市場，提供了有關主要參與者和市場佔有率、主要趨勢、創新產品和技術以及競爭格局的資訊。

市場模型的主要內容如下。

尿路支架已經上市以及不斷變化的競爭格局

• 對主要產業趨勢的考察
• 依細分市場劃分的泌尿支架市場年收入與市場前景（2015-2033年）
• 有關單位數量、平均售價和市場價值的市場級資料

全球、區域和國家層面的特定市場考察

• 依地區細分全球趨勢的特定市場定性資訊和國家考察
• 泌尿支架市場SWOT分析
• 泌尿支架市場競爭動態思考及趨勢

掌握包括醫療保健系統概述真實情況，促進市場了解。市場進入部分還提供有關償付政策和監管環境的訊息，能夠更深入地研究市場動態。

• 各國醫療保健系統概覽
• 依國家/地區劃分的償付政策
• 各國醫療科技監理狀況

目標公司

• Boston Scientific Corp
• Cook Medical Inc
• CR Bard Inc
• Olympus Corp
• Coloplast A/S
• Applied Medical Resources Corporation
• Allium Medical Solutions Ltd
• Pnn Medical A/S
• SRS Medical Systems Inc

Urinary Tract Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Nephrology and Urology Devices therapeutic area.

A urinary tract stent is a small tube, made of either metal or polymer material, that is inserted into the urinary tract to keep it open. These tubular devices, composed of polymers or metal, are placed in the urinary tract or ureter to treat or prevent blockages that hinder urine flow from the kidney to the bladder.

Urolithiasis is a condition in which chemicals found in urine precipitate to form a solid object known as a kidney stone. After formation, the stone may stay in the kidney or travel down in the urinary tract into the ureter. Kidney stones may be formed from several materials including oxalic acid, uric acid, struvite, or cystine.The increasing number of treatments for Urolithiasis and Benign Prostatic Hyperplasia (BPH), especially requiring stent placement and recurrent stenting, has been identified as the primary growth driver for the urinary tract stents market.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Urinary Tract Stents and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Urinary Tract Stents market revenue by segment and market outlooks from 2015 - 2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Urinary Tract Stents market.
• Competitive dynamics insights and trends provided for Urinary Tract Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Cook Medical Inc, CR Bard Inc, Olympus Corp, Coloplast A/S, Applied Medical Resources Corporation, Allium Medical Solutions Ltd, Pnn Medical A/S, SRS Medical Systems Inc

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Urinary Tract Stents marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Urinary Tract Stents market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Urinary Tract Stents market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Urinary Tract Stents market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.